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Abstract
Background. It is not clear whether relaxation therapies are more or less effective than cog-
nitive and behavioural therapies in the treatment of anxiety. The aims of the present study
were to examine the effects of relaxation techniques compared to cognitive and behavioural
therapies in reducing anxiety symptoms, and whether they have comparable efficacy across
disorders.
Method. We conducted a meta-analysis of 50 studies (2801 patients) comparing relaxation
training with cognitive and behavioural treatments of anxiety.
Results. The overall effect size (ES) across all anxiety outcomes, with only one combined ES in
each study, was g =−0.27 [95% confidence interval (CI) =−0.41 to −0.13], favouring cognitive
and behavioural therapies (number needed to treat = 6.61). However, no significant difference
between relaxation and cognitive and behavioural therapies was found for generalized anxiety
disorder, panic disorder, social anxiety disorder and specific phobias (considering social anx-
iety and specific phobias separately). Heterogeneity was moderate (I2 = 52; 95% CI = 33–65).
The ES was significantly associated with age ( p < 0.001), hours of cognitive and/or behav-
ioural therapy ( p = 0.015), quality of intervention ( p = 0.007), relaxation treatment format
( p < 0.001) and type of disorder ( p = 0.008), explaining an 82% of variance.
Conclusions. Relaxation seems to be less effective than cognitive and behavioural therapies in
the treatment of post-traumatic stress disorder, and obsessive–compulsive disorder and it
might also be less effective at 1-year follow-up for panic, but there is no evidence that it is
less effective for other anxiety disorders.
Background
Anxiety disorders are the most prevalent mental disorders, with lifetime prevalence rates up to
14.5% in the European epidemiological surveys (Alonso & Lepine, 2007), or even up to 33.7%
in the USA (Kessler et al. 2012). They are associated with considerable impairment and
decreased levels of health-related quality of life, as well as a high comorbidity with other men-
tal disorders, health care utilization and economic burden for society (Bandelow & Michaelis,
2015; Bandelow et al. 2015). Depending on the core symptoms and the nosological system,
individuals suffering from anxiety may be classified into DSM-IV categories such as general-
ized anxiety disorder (GAD), with a 3.7% lifetime prevalence (Ruscio et al. 2017), panic dis-
order (1.7%) (de Jonge et al. 2016), agoraphobia (0.8%) (Alonso & Lepine, 2007), social phobia
(12.1%) (Ruscio et al. 2008) and specific phobias (7.4%) (Wardenaar et al. 2017). They might
also be classified into diagnostic categories already discontinued in the most recent DSM-5,
but traditionally used within this type of disorders, such as obsessive–compulsive disorder
(OCD, 1–3%) (Hirschtritt et al. 2017), and post-traumatic stress disorder (PTSD, 3.9%)
(Koenen et al. 2017).
It has been established that cognitive therapy (CT), behavioural therapy (BT), and cognitive
and behavioural therapy (CBT), all together referred from now on as (C)BTs, are effective in
the treatment of anxiety disorders (Cuijpers et al. 2016), although other treatments, e.g. psy-
chopharmacological drugs, might present even higher effects than those achieved with (C)BTs
(Bandelow & Michaelis, 2015; Bandelow et al. 2015). Relaxation training has also been used to
treat anxiety with some degree of success (Hayes-Skelton et al. 2013). Relaxation training
includes methods such as progressive muscle relaxation (PMR), which emphasizes reducing
muscle tension and achieving relaxed states (Bernstein & Borkovec, 1973), and applied relax-
ation (AR), which focuses on making relaxation as a skill to be used in natural settings (Öst,
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1987). Relaxation techniques are based on the premise that anx-
iety involves interacting central and peripheral physiological sys-
tems, each of them influencing the others, so that changes in
reducing one channel should also reduce the others. These inter-
ventions have usually been used as active control groups com-
pared with (C)BTs, although the effects of relaxation compared
to (C)BTs when treating anxiety disorders are not clear in general
terms, and neither their relative effects in the treatment of one
anxiety disorder compared with another. A previous
meta-analysis comparing (C)BTs and relaxation therapy (Siev &
Chambless, 2007) found no differences in the treatment of
GAD, although a group considered in this study as relaxation
therapy, in fact, included some components of BT (Butler et al.
1991). The referred meta-analysis proposed some possible differ-
ences when treating panic disorder, favouring (C)BTs, and sug-
gesting specificity of treatment to anxiety class disorders.
However, the number of studies given support to this conclusion
were scarce, and new studies adding evidences seems to be
appeared since then. No other meta-analysis comparing (C)BTs
and relaxation has been done since, while many new studies
have been conducted. Furthermore, the referred early
meta-analysis only focused on GAD and panic disorder, while a
considerable number of trials have also compared the effects of
(C)BTs and relaxation in other distinct anxiety disorders. For
instance, it has recently been said that a range of interventions
is effective in the management of OCD, but considerable uncer-
tainty exists regarding their relative efficacy (Skapinakis et al.
2016).
We decided therefore to conduct a meta-analysis to examine
the efficacy of relaxation compared to (C)BTs, and whether
their relative efficacy varies across different anxiety disorders.
Method
We followed the PRISMA guidelines for systematic reviews and
meta-analyses, and the recommendations of the Cochrane
Collaboration (Moher et al. 2010; Higgins & Green, 2011). The
protocol was registered with PROSPERO (registration number
CRD42015026254).
Identification and selection of studies
We built a database of papers searching four major bibliograph-
ical databases (PubMed, PsycInfo, Embase and the Cochrane
Database of randomized trials), by using both MeSH terms and
text words indicative of anxiety disorders and relaxation trainings,
with filters for randomized controlled trials (RCTs), but with no
(C)BT specifications, to avoid the risk of letting out studies with
specific (C)BT interventions, and to construct an open and con-
tinuously updated database for future research. In these database
searches, we identified 13 477 titles and abstracts, from PubMed
(3556), PsycInfo (1154), Embase (6395), and the Cochrane
Database of randomized trials (2372). From the 13 477 records,
13 326 were excluded because they did not meet criteria or
were duplicates. Moreover, 52 references were added from the ref-
erence lists of selected articles and metadata. In total 203 publica-
tions were retrieved for possible inclusion in the database. The full
search string for PubMed is given in the online Supplementary
Material 1. The deadline of the searches was 24 March 2017.
The inclusion criteria of studies were: (a) RCTs, (b) in which
patients met diagnostic criteria for anxiety according to a formal
interview or scored above a specific cut-off on a self-rating scale,
(c) with age >17 years, (d) published in a peer-review journal, (e)
comparing at least a group of relaxation therapy with a group of
(C)BT. Relaxation techniques included those focused in changing
physiological responses of anxiety, but did not include bio-
feedback or mindfulness procedures (and other meditation tech-
niques such as yoga, tai chi, qigong or spiritual therapies, which
will be analysed in a separate meta-analysis). (C)BTs were defined
as therapies aimed at cognitive restructuring or at changing cur-
rent anxiety behaviour, such as exposure. Studies on eye move-
ment desensitization and reprocessing, interpersonal therapy or
psychodynamic interventions were excluded, because they do
not offer the cognitive and behavioural strategies that are typically
offered in (C)BTs. Third-generation (C)BTs, e.g. acceptance-
based behaviour therapy, were included. Comorbid mental or
somatic disorders were not excluded if anxiety was the primary
diagnosis or in the case of dual diagnosis. We excluded studies
that did not report enough data to calculate standardized effect
sizes (ESs) (e.g. qualitative, predictive or mediation studies with
no other data), as well as papers that reported about a trial that
already included the same parameters. No language restriction
was applied. Anxiety disorders were defined according to the
DSM-IV and included GAD, panic disorder, social anxiety dis-
order, specific phobias, as well as disorders that were categorized
as anxiety disorder in the DSM-IV but not in the DSM-5 (OCD
and PTSD).
Data extraction and quality assessment
Two reviewers independently screened citations for inclusion by
examining titles and abstracts, and the full text of the potentially
relevant studies. Data extraction and quality assessment were con-
ducted by two independent researchers, using a predefined data
extraction sheet. In case of disagreement, resolution was reached
through discussion with a third researcher.
We coded aspects of the studies, including year of publication,
country, intervention format (individual, group), number of par-
ticipants, setting for delivery, who delivered, follow-up measure-
ments (post-test, 3, 12, >12 months); anxiety outcome domain
(physiological, e.g. skin conductance; cognitive, e.g. worries;
behavioural, e.g. avoidance; mixed, e.g. Hamilton Anxiety
Scale); depression outcomes (e.g. Beck Depression Inventory);
credibility; acceptability (completion rate); others (e.g. general
functioning); patient characteristics (age; sex as percentage of
women); type of anxiety disorder (PTSD, OCD, social phobia,
specific phobia, panic, GAD, mixing anxiety disorders); hours
of relaxation (based on the number of sessions and the length
of the intervention); relaxation technique (PMR, AR, others);
relaxation treatment format (therapist, self-guided, therapist +
self-guided); (C)BT technique (cognitive restructuring, exposure,
cognitive restructuring + exposure, others); hours of (C)BT
therapy.
Risk of bias was assessed using four criteria of the Cochrane
Collaboration’s tool (Higgins & Green, 2011), including adequate
generation of allocation sequence, concealment of allocation to
conditions, prevention of knowledge of the allocated intervention
(masking of assessors), and dealing with incomplete outcome data
(positive when intention-to-treat analyses were conducted).
Quality of interventions was evaluated according to three criteria
(Chambless & Hollon, 1998): use of a treatment manual, provi-
sion of therapy by specifically trained therapists and verification
of treatment integrity during the study.
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Statistical analysis
For each comparison between a relaxation condition and a (C)BT
group, we calculated Hedges’ g as an ES, assuming normal distri-
butions with equal variances. The ES indicated the differences
between the two groups and the 95% confidence interval (95%
CI), at post-test or follow-up. We choose Hedges’ g as the ES
because it corrects for small sample bias (Hedges, 1981). In gen-
eral, it has been proposed that an ES of 0.20 is small; of 0.50 is
moderate and of 0.80 is large (Cohen, 1988). When more than
one outcome measure was provided in each of the groups of vari-
ables referred above (anxiety, depression, credibility, acceptability,
others and all the variables together), outcomes were pooled
within the study before pooling across studies (the specific vari-
ables used are in Appendix 2), so that each comparison used
only one effect (Borenstein et al. 2009). For continuous outcomes,
the ES was calculated by subtracting the post-test or follow-up
mean score of the (C)BT group, from the mean score of the relax-
ation group, and dividing the result by the pooled standard devi-
ation. When dichotomous outcomes were reported, we estimated
the corresponding Hedges’ g ES by the procedures provided by
Borenstein et al. (2009). To facilitate the clinical interpretation
of Hedges’ g, we transformed the ESs into the number needed
to treat (NNT), with the conversion of Kraemer & Kupfer
(2006). The NNT indicates the number of patients that have to
be treated in order to generate one additional positive outcome
(Laupacis et al. 1988). Acceptability was defined as study drop-out
for any reason. In this case, we calculated the relative risk (RR) of
dropping-out of (C)BTs compared with relaxation, as well as the
risk difference. NNT was directly calculated for acceptability as 1
divided by the risk difference. Because considerable heterogeneity
among studies was expected, the pooled ES was calculated using
the random-effects model. We examined heterogeneity using
the I2 statistic, and 95% CI around I2 using the non-central χ2
approach (Ioannidis et al. 2007). A value of 0% indicates no
observed heterogeneity, 25% low, 50%, moderate and 75%, high
heterogeneity.
Subgroup analyses were conducted according to the
mixed-effects model, to evaluate possible differences in ESs
according to the format of intervention (group, individual), anx-
iety disorder (PTSD, OCD, any phobia, panic, GAD, mixed),
relaxation technique (PMR, AR, others), (C)BT technique (cogni-
tive restructuring, exposure, cognitive restructuring + exposure,
others) and relaxation treatment format (therapist, self, therapist
+ self), as possible sources of heterogeneity. The mixed-effects
model pools studies within the subgroups according to the
random-effects model, and test for significant differences between
subgroups with the fixed-effects model (Borenstein et al. 2009).
Multivariate meta-regression analyses, with the anxiety ES as
the dependent variable, were also conducted by the method of
moments, indicating by a Z-value and its associated p value
whether there was a significant relationship between independent
variables and ES. As predictors, we entered all the variables of the
previous subgroup analyses, and also the following continuous
variables: age, sex (% females), hours of relaxation, hours of (C)
BT, risk of bias and quality of intervention. Possible collinearity
problems between predictors were evaluated by using the variance
inflation factor (VIF). Moreover, we also conducted a manual
back-step meta-regression analysis, in which we dropped the
least significant variable in each step, until only significant predic-
tors were retained in the model, looking for a parsimonious
model (Cuijpers et al. 2016). The R2 value, as a percentage of
the explained variance from the total variance in true effects by
the parsimonious model, was also calculated, as well as a simul-
taneous test for all coefficients, and a test of goodness fit by
using the Q statistic.
Publication bias was evaluated by visually inspecting the fun-
nel plot on anxiety ESs and by Duval and Tweedie’s trim and
fill procedure (Duval & Tweedie, 2000), which provides the num-
ber of studies probably absent, and gives an estimate of the ES
after the publication bias has been taken into account, supposing
that the total studies should be distributed evenly on both sides of
the mean ES. The Begg and Mazumdar rank correlation test was
applied to test whether the adjusted and observed ESs differed sig-
nificantly from each other (Begg & Mazumdar, 1994), and Egger’s
test of the intercept to contrast the null hypothesis of bias absence
was also conducted (Egger et al. 1997). Finally, we also calculated
Rosenthal’s fail-safe N test (Rosenthal, 1979), which computes the
number of missing studies that would need to be added to the
analysis to yield a statistically insignificant overall effect, assuming
that the effect in the hidden studies is nil.
All the tests were set with a significance level of α < 0.05, and
they were two-tailed, except for the bias-related test, which were
one-tailed. Data were analysed using the Comprehensive
Meta-Analysis-3.0, Stata-12 and R-3.1.1 statistical packages.
Results
Fifty studies on anxiety disorders [reported in 59 papers, with 65
possible comparisons between (C)BT v. relaxation using anxiety
outcomes] met inclusion criteria for the meta-analysis (Fig. 1)
and were analysed. Selected characteristics of the 50 included
studies are presented in the online Supplementary Material 2,
and their references are given in the online Supplementary
Material 3.
Characteristics of included studies
The 50 studies included 2801 participants: 1575 in the (C)BT
groups and 1226 in the relaxation groups. The average number
of patients per condition was 25. There were 11 studies on
GAD; 13 studies on panic (four without or with mild agorapho-
bia, one without or with mild/moderate agoraphobia, three with-
out or with agoraphobia, five with agoraphobia); 15 studies on
any phobia (one agoraphobia, four social phobia, two flying pho-
bia, two death phobia, three blood phobia, one dental phobia, one
acrophobia, one claustrophobia); three studies on OCD (one
dually diagnosed); four studies on PTSD and four studies mixing
different anxiety disorders: one study with agoraphobia, social
phobia and specific phobia; one study with social phobia and
snake phobia (both studies were finally considered as any phobia
studies); one study with social phobia, GAD, panic + alcohol use
disorder; one study with social phobia, panic with/without agora-
phobia, GAD, specific phobia and OCD. There were differences in
the relaxation technique used, although AR was the most included
(in 28 of the 65 comparisons), being ‘therapist + self-guided’ the
main application form. There were also differences in terms of the
(C)BT intervention, but the majority were BT groups (38 of the 65
comparisons), with exposure as the most used technique. The
interventions also differed in terms of treatment format (individ-
ual, group), and the number of therapy hours, with a relaxation
range from 0.3 to 84 h, and a (C)BT range from 0.3 to 96 h.
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The quality of the studies and interventions also varied. Only
three studies met all four study quality criteria, 30 met two or
three criteria and the remaining 17 had a low quality, with one
of the four criteria. Forty-eight studies reported an adequate
sequence generation (two studies from the 1970s were unclear,
and therefore a sensitivity analysis dropping these two studies
was conducted). Thirty studies reported concealment of allocation
to conditions. Ten studies reported prevention of knowledge of
the allocated intervention. Thirteen studies deal with incomplete
outcome data. On the other hand, 20 studies met all three inter-
vention quality criteria, 23 studies met one or two criteria and
seven studies met none.
Overall effects on anxiety outcomes
From the 50 included studies, we compared the effects of relax-
ation with (C)BT in 65 possible comparisons. The overall ES
for anxiety outcomes was g =−0.25 (95% CI = −0.38 to −0.13),
favouring (C)BT, which corresponds with a NNT of 7.10.
Heterogeneity was moderate (I2 = 53; 95% CI = 38–65).
Inspection of a forest plot of the ES and their 95% CI indicated
that there were potential outliers. Excluding the five ES that did
not overlap with the 95% CI of the pooled ES resulted in a
lower ES (g = −0.21; 95% CI =−0.31 to −0.12; NNT = 8.35), as
well as reductions in heterogeneity (I2 = 15; 95% CI = 0–39).
Eliminating two old studies with no clear allocation in their report
showed similar values than those obtained in the overall estimate,
and this was also the case when removing seven studies which
used desensitization (a BT technique that makes use of relax-
ation). Given that 10 studies included multiple (C)BT groups
which were considered in the same analysis, we conducted an
analysis in which only one ES in each study was included (either
the largest or the smallest ES in each study, and also a combin-
ation of all of them). The resulting ESs ranged from g =−0.30
to g =−0.20 (with a combined ES of g =−0.27; 95% CI =−0.42
to −0.13; NNT = 6.61), and heterogeneity remained similar to
the overall values (Table 1). We also estimated the ESs for each
anxiety outcome domain. The ES of the mixed domain outcomes
category was the only category remaining significant results, with
a similar ES to the overall estimation. The separate analysis of the
assessor- and self-reported outcomes showed similar ESs, but het-
erogeneity seemed to be higher in self-reported outcomes. Finally,
we found similar results when including only high-quality inter-
ventions (meeting the three criteria), although ES seemed to bene-
fit more to (C)BT groups whether only high-quality studies
(meeting three or four criteria) were included (g =−0.42; 95%
CI = −0.67 to −0.18; NNT = 4.26).
Some indications of publication bias were found. Duval and
Tweedie’s trim and fill procedure indicated that six studies
might be missing, and the pooled adjusted ES was −0.30 (95%
CI = −0.45 to −0.19; NNT = 5.95). However, Begg and
Mazumdar rank correlation was not significant (τ = 0.02; p =
0.410), and Egger’s regression intercept was also not significant
(intercept = 0.25; 95% CI =−0.72 to 1.23; p = 0.303). The fail-safe
N was 496. Therefore, it would be needed to include 496 ‘null’
studies to find a statistically insignificant overall effect. In other
words, 7.63 missing studies for every observed comparison
would be needed for the effect to be nullified.
Overall effects on other outcomes
We calculated (Table 1) the overall ES on depression, with no sig-
nificant differences (g =−0.03; 95% CI = −0.26 to 0.20), but high
heterogeneity (I2 = 75; 95% CI = 65–83); credibility, with no sig-
nificant differences (g = −0.03; 95% CI =−0.20 to 0.14), and
low heterogeneity (I2 = 24; 95% CI = 0–55); and on other out-
comes (general functioning, adverse events, medication use, sub-
stance abuse, quality of life, social adjustment, performance,
memory, metacognition, mindfulness and experiential avoidance),
with low and significant differences (g =−0.27; 95% CI =−0.37
to 0.17; NNT = 6.63), and low heterogeneity (I2 = 15; 95% CI =
0–41).
The overall estimate of acceptability (online Supplementary
Material 4) did not show significant differences (RR = 1.13; 95%
Fig. 1. Flow chart of inclusion of studies.
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CI = 0.94–1.37), with zero heterogeneity (I2 = 0; 95% CI = 0–32).
Only OCD showed significant differences in acceptability (RR =
1.89; 95% CI = 1.14–3.12; NNT = 16.67), favouring relaxation,
and PTSD might present a trend in the same direction, but
there were no significant differences in this subgroup analysis.
On the contrary, they were subgroup differences regarding the
relaxation technique ( p = 0.019), and the (C)BT technique ( p =
0.018), being that both PMR (RR = 1.65; 95% CI = 1.181–2.32;
NNT = 25.00) and exposure (RR = 1.52; 95% CI = 1.16–1.99;
NNT = 20), favoured a greater acceptance of relaxation, compared
with (C)BT.
Taking into account all the outcomes referred, differences
between relaxation and (C)BT were low but significant (g =
−0.21; 95% CI =−0.31 to −0.11; NNT = 8.51) (Table 1).
Subgroup analyses on anxiety outcomes
A series of subgroup analyses were conducted to examine whether
characteristics of studies were related to the ESs (Table 2). The
separate analysis of social phobia (g = −0.16; 95% CI = −0.80 to
0.48) and specific phobias (g =−0.17; 95% CI =−0.37 to 0.04)
showed similar ESs, with no significant effects, so they were
merged in a category named any phobia (including two studies
which mixed different phobias) to gain statistical power. In this
condition, we found that ES was significantly associated with
type of disorder ( p = 0.004), being significant PTSD (g = −0.60;
95% CI =−0.94 to −0.27; NNT = 3.02), OCD (g = −0.58; 95%
CI = −0.90 to −0.27; NNT = 3.12) and any phobia (g = −0.22;
95% CI = −0.42 to −0.03; NNT = 8.02), favouring (C)BT. As
can be seen in Fig. 2, the same occurred when only a single com-
parison in each study (based on a combined ES) was used, but
showing higher ES values (Fig. 2) also graphically shows the
width of the CIs, and that almost all studies were underpowered,
making it difficult to reach definite conclusions. These results
remained similar for PTSD and OCD when only using high-
quality studies, but any phobia lost significance, maybe due to
the low number of studies included (online Supplementary
Material 5). We also found that ES was significantly related to
relaxation technique ( p = 0.001), being that PMR (g = −0.47;
95% CI =−0.63 to −0.30; NNT = 3.87) performed worse than
AR (g = −0.05; 95% CI = −0.19 to 0.09). ES was also associated
with relaxation application ( p = 0.001), with self-applied (g =
−0.63; 95% CI = −0.83 to −0.44; NNT = 2.90) performing
worse than therapist-applied (g =−0.22; 95% CI = −0.39 to
−0.06; NNT = 8.02), or therapist + self-applied (g =−0.16; 95%
CI = −0.34 to 0.02). We finally found no significant differences
according to the format of intervention ( p = 0.197), or (C)BT
technique ( p = 0.319).
Table 1. Effects of relaxation compared with (C)BT for anxiety disorders
Ncomp g p 95% CI I
2 95% CI NNTa
Anxiety (overall) 65 −0.25 <0.001 −0.38 to −0.13 53 38–65 7.10
One ES per study, combined 49 −0.27 <0.001 −0.42 to −0.13 52 33–65 6.61
One ES per study, lowest 49 −0.30 <0.001 −0.45 to −0.16 55 38–67 5.89
One ES per study, highest 49 −0.20 0.006 −0.35 to −0.06 57 40–68 8.72
Five outliers excluded 60 −0.21 <0.001 −0.31 to −0.12 15 0–39 8.35
Unclear allocation excluded 62 −0.25 <0.001 −0.38 to −0.12 55 40–66 7.10
Desensitization excluded 57 −0.25 <0.001 −0.39 to −0.12 58 43–68 7.10
Physiological outcomes 27 −0.01 0.866 −0.17 to 0.14 25 0–54 ‒
Behavioural outcomes 33 −0.13 0.266 −0.35 to 0.10 64 47–75 ‒
Cognitive outcomes 30 −0.17 0.181 −0.42 to 0.08 75 64–82 ‒
Mixed domain outcomes 57 −0.28 <0.001 −0.41 to −0.15 55 40–67 6.44
Assessor-reported 50 −0.24 0.001 −0.38 to −0.10 37 11–56 7.48
Self-reported 60 −0.23 0.001 −0.37 to −0.10 61 48–70 7.71
High-quality studiesb 20 −0.42 0.001 −0.67 to −0.18 68 49–80 4.26
High-quality interventionsc 23 −0.29 0.022 −0.53 to −0.04 67 49–79 6.26
Other outcomes
Depression 30 −0.03 0.796 −0.26 to 0.20 75 65–83 ‒
Credibility 22 −0.03 0.753 −0.20 to 0.14 24 0–55 ‒
Othersd 50 −0.27 <0.001 −0.37 to −0.17 15 0–41 6.63
All outcomese 66 −0.21 <0.001 −0.31 to −0.11 12 0–36 8.51
Ncomp, number of comparisons; g, Hedges’ g ES measure; 95% CI, 95% confidence interval; p, p value according to the random effects model; I
2, heterogeneity; NNT,
numbers-needed-to-treat.
aNNT for non-significant results are not reported.
bIncluding studies that meet three or four study quality criteria.
cIncluding studies that meet the three intervention quality criteria.
dIncluding general functioning, adverse events, medication use, substance abuse, quality of life, social adjustment, performance, memory, metacognition, mindfulness and experiential
avoidance.
eIncluding anxiety, depression, credibility, acceptability and others.
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Time-point effects on anxiety outcomes
The overall small disadvantage of relaxation compared with (C)
BT remained significant from post-test to 12 months follow-up,
but differences were no longer significant when the follow-up
was 1 year or more after post-test (online Supplementary
Material 6). When comparing anxiety disorders by each time
point, we also observed significant differences at post-test ( p =
0.002), 3 months ( p < 0.001) and 12 months follow-up ( p =
0.007). Specifically, GAD showed no significant differences at
any of the time-point effects; panic only showed significant differ-
ences at 12 months follow-up (g =−0.31; 95% CI = −0.56 to
−0.06; NNT = 5.76); any phobia showed significant differences
at post-test (g = −0.23; 95% CI = −0.42 to −0.03; NNT = 7.81),
and 3 months follow-up (g =−0.79; 95% CI = −1.16 to −0.43;
NNT = 3.35); OCD showed significant differences at post-test
(g =−0.60; 95% CI =−0.94 to −0.27; NNT = 3.04) and at 12
months follow-up (g =−1.16; 95% CI = −1.85 to −0.48; NNT =
1.70), although there were no OCD comparisons at 3 months,
and only one at 12 months follow-up; PTSD showed significant
differences at post-test (g =−0.62; 95% CI =−0.95 to −0.29;
NNT = 2.95), at 3 months follow-up (g =−0.56; 95% CI =
−0.90 to −0.22; NNT = 3.25) and at 12 months follow-up, but
with just one comparison at this point (g = −1.36; 95% CI =
−2.30 to −0.41; NNT = 1.51). There were no evidence of differ-
ences in any of the disorders at 1 year or more after post-test
( p = 0.838), although the number of comparisons was drastically
reduced, and there were no comparisons on OCD nor PTSD.
Multivariate meta-regression analysis
A multivariate meta-regression analysis with the overall ES based
on the anxiety outcomes as dependent variable was conducted. As
predictors, we entered all the subgroup analyses variables, and the
other continuous outcomes referred above. However, hours of
relaxation and hours of (C)BT showed collinearity problems
(the VIF between them was 10.43). Therefore, hours of relaxation
Table 2. Effects of relaxation compared with (C)BT for anxiety disorders: subgroup analyses
Ncomp g p
a 95% CI I2 95% CI pb NNTc
Format of intervention
Group 18 −0.14 0.341 −0.42 to 0.14 66 45–79 0.197 ‒
Individual 40 −0.34 <0.001 −0.48 to −0.21 33 1–55 5.25
Anxiety disorder
PTSD 6 −0.60 <0.001 −0.94 to −0.27 0 0–75 0.004 3.02
OCD 5 −0.58 <0.001 −0.90 to −0.27 60 0–85 3.12
PHOBd 26 −0.22 0.024 −0.42 to −0.03 27 0–55 8.02
PANIC 16 −0.09 0.369 −0.29 to 0.11 32 0–63 ‒
GAD 10 −0.01 0.999 −0.20 to 0.20 0 0–62 ‒
MIX 2 −0.95 0.279 −2.67 to 0.77 97 –e ‒
Relaxation technique
PMR 22 −0.47 <0.001 −0.63 to −0.30 37 0–62 0.001 3.87
AR 28 −0.05 0.460 −0.19 to 0.09 12 0–44 ‒
Othersf 15 −0.18 0.373 −0.58 to 0.22 73 55–84 ‒
(C)BT technique
Cognitive restructuring 8 −0.10 0.431 −0.33 to 0.14 0 0–68 0.319 ‒
Exposure 28 −0.26 0.005 −0.44 to −0.08 51 25–68 6.83
Cog. restruct. + exposure 11 −0.47 0.008 −0.81 to −0.12 75 55–86 3.87
Othersg 18 −0.15 0.283 −0.42 to −0.12 45 3–68 ‒
Relaxation application
Therapist + self 40 −0.16 0.089 −0.34 to 0.02 55 36–69 0.001 ‒
Therapist 18 −0.22 0.009 −0.39 to −0.06 30 0–61 8.02
Self 7 −0.63 <0.001 −0.83 to −0.44 5 0–72 2.90
Ncomp, number of comparisons; g, Hedges’ g ES measure.
ap value according to the random-effects model. 95% CI, 95% confidence interval; I2, heterogeneity; NNT, numbers-needed-to-treat.
bThe p values in this column indicate whether the difference among the effect sizes in the subgroups is significant.
cNNT for non-significant results are not reported.
dAny phobia. PMR, progressive muscle relaxation; AR, applied relaxation.
eThe 95% CI of I2 cannot be calculated when the number of studies is two or smaller.
fThis category includes relaxation techniques such as pulsed audio-photic stimulation, cue-controlled relaxation, relaxing without initial muscle tensing, music relaxation or mixed
techniques.
gThis category includes (C)BT techniques such as paradoxical intention, counterfactual reasoning, metacognitive techniques, activation techniques, coping skills, social skills or
acceptance-based behaviour techniques.
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was removed (it also showed higher VIF values with the rest of
variables). As can be seen in Table 3, relaxation treatment format
remained as a significant predictor of ES, while adjusting for the
other study features, and they also were age and hours of (C)BT.
The results of the parsimonious model, using the manual back-
step meta-regression analysis, indicated that age, hours of (C)
BT, quality of intervention, type of disorder and relaxation treat-
ment format were significantly associated with the ES, explaining
a 82% of total variance. The simultaneous test of all coefficients of
the parsimonious model was significant (Q = 43.09; df = 10;
p < 0.001), and the test that unexplained variance is zero which
pointed a good fit (Q = 46.35; df = 40; p = 0.227).
Discussion
We found that (C)BT, compared with relaxation, had a small but
statistically significant effect in the treatment of anxiety symp-
toms, and it was maintained 1 year follow-up. The clinician-rated
outcomes and the self-report measures indicated similar values.
Surprisingly, significant effects only appeared when using mixed-
domain outcomes, but not in physiological, behavioural or cogni-
tive outcomes analysed separately. Around one-third of studies
presented adequate quality (none or one possible source of
bias), and 40% of studies implemented high-quality interventions.
The specific analysis of these high-quality studies and interven-
tions, as well as the different sensitivity analyses developed,
maintained results in the same direction, with small ESs, favour-
ing (C)BT. Relaxation therapy has been proposed as an active
control or even as a treatment strategy to reduce anxiety symp-
toms (Hayes-Skelton et al. 2013), so it is not surprising that
small ESs were found as a result of the referred comparison.
We also found that age, hours of (C)BT, quality of intervention,
relaxation treatment format and type of anxiety disorder were
related to ES, explaining much of the heterogeneity. Our results
suggest that the older patients, the less benefits obtained from
(C)BT, something that might be explained because anxiety disor-
ders reach a peak in middle age, and tend to decrease with older
age (Bandelow & Michaelis, 2015; Bandelow et al. 2015), may be
an stage easier to be released from anxiety with techniques
focused on the physiological system. However, we cannot make
strong inferences of individual characteristics of patients related
to treatment outcomes, because to document this, developing
moderator analyses within each RCT, with larger sample sizes,
would be needed. It was also observed that the greater number
of (C)BT hours, the higher effects favouring (C)BT were found,
something easy to be understood. In the same sense, the higher
quality of interventions, the higher benefits to (C)BT, which sug-
gest that, if we want to add some extra effectiveness to (C)BT
when treating anxiety, it should be designed and applied with spe-
cial attention and care. It was also found that when relaxation was
applied, totally or partially, by a therapist, relaxation therapy was
benefited, maybe because it supposed a greater adherence to the
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practice, or perhaps implied a practice of higher quality. Finally,
different effects were found depending on the anxiety disorder,
being that PTSD, OCD and any phobia may be more treatable
by using (C)BT, the latter in line with what was pointed for social
anxiety (Mayo-Wilson et al. 2014), although panic might also
benefit from (C)BT, as previously proposed (Pompoli et al.
2016; Siev & Chambless, 2007), specifically at 1 year follow-up,
so it would be worth to examine long-term effects in panic, as
it has been recently pointed out (Imai et al. 2016). However, no
significant difference between relaxation and (C)BT was found
in social anxiety and specific phobias considered separately.
Any difference for GAD was also not found in line with a
previous meta-analysis (Siev & Chambless, 2007), something
that reinforces the proposal of relaxation to treat it
(Hayes-Skelton et al. 2013). In general, it has already been sug-
gested that (C)BT may have a different impact on the distinct
anxiety disorders (Cuijpers et al. 2016).
There were no significant differences in other distinct out-
comes such as depression, nor treatment credibility, but there
were in a mixed group of variables formed by general functioning
measures, favouring (C)BT, but equally with a small ES. There
were no significant differences in acceptability between (C)BT
and relaxation therapy, although the use of both PMR, as a relax-
ation technique, or exposure, as a (C)BT technique, favoured
Table 3. Features of studies comparing relaxation with (C)BT for anxiety: multivariate meta-regression
Full model Parsimonious model
Coefficient (95% CI) pa pb Coefficient (95% CI) pa pb
Intercept −1.55 (−3.81 to 0.71) 0.180 −2.08 (−3.27 to −0.89) 0.001
Age (continuous) 0.04 (0.01–0.07) 0.023 0.04 (0.02–0.07) <0.001
Sex (continuous, % females) <0.01 (−0.01 to 0.01) 0.969 ‒ ‒
Hours of CBT (continuous) −0.02 (−0.03 to −0.01) 0.034 −0.02 (−0.03 to −0.01) 0.015
Risk of bias (continuous) −0.01 (−0.29 to 0.27) 0.937 ‒ ‒
Quality of intervention (continuous) −0.14 (−0.39 to 0.12) 0.292 −0.19 (−0.32 to −0.05) 0.007
Individual format (v. group) −0.04 (−0.42 to 0.35) 0.851 ‒ ‒
Disorder
PTSD ref. 0.343 ref. 0.008
OCD 0.25 (−0.50 to 0.99) 0.516 0.13 (−0.50 to 0.76) 0.686
PHOBc 0.37 (−0.36 to 1.11) 0.318 0.12 (−0.39 to 0.64) 0.636
PANIC 0.51 (−0.11 to 1.12) 0.105 0.34 (−0.08 to 0.76) 0.112
GAD 0.60 (−0.11 to 1.31) 0.098 0.33 (−0.15 to 0.82) 0.179
MIX −0.21 (−1.01 to 0.58) 0.600 −0.42 (−0.97 to −0.13) 0.137
Relaxation technique
PMR ref. 0.653
AR −0.19 (−0.64 to 0.25) 0.392 ‒ ‒
Otherd −0.21 (−0.76 to 0.35) 0.463 ‒ ‒
(C)BT technique
cog. restructuring ref. 0.590
cog. restruct. + exposure −0.10 (−0.60 to 0.40) 0.698 ‒ ‒
exposure 0.13 (−0.40 to 0.66) 0.624 ‒ ‒
othere −0.11 (−0.71 to 0.49) 0.719 ‒ ‒
Relaxation application
Self ref. 0.004 ref. <0.001
Therapist 1.08 (0.43 to 1.73) 0.001 0.95 (0.49 to 1.40) <0.001
Therapist + self 0.87 (0.26 to 1.48) 0.005 0.63 (0.16 to 1.10) 0.008
Full model: meta-regression analysis including all the predictors together. Parsimonious model: meta-regression using the manual back-step analysis. Coefficient: standardized regression
coefficients. 95% CI, 95% confidence interval.
ap value according to the random-effects model by using the method of moments (MM) computational procedure.
bThe p values in this column indicate whether the difference among the coefficients in the subgroups is significant.
cAny phobia. PMR, progressive muscle relaxation; AR, applied relaxation.
dThis category includes relaxation techniques such as pulsed audio-photic stimulation, cue-controlled relaxation, relaxing without initial muscle tensing, music relaxation or mixed
techniques.
eThis category includes (C)BT techniques such as paradoxical intention, counterfactual reasoning, metacognitive techniques, activation techniques, coping skills, social skills or
acceptance-based behaviour techniques.
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significantly the acceptability of relaxation compared with (C)BT.
It might be due because coping with the feared stimulus is an
uncomfortable situation which could cause higher attrition
rates. In general, taking into account all the referred outcomes
together, (C)BT showed a small but statistically significant effect
in the treatment of anxiety disorders, compared with relaxation
therapy.
Limitations
This meta-analysis has several limitations. Firstly, the small num-
ber of studies in some of the subgroup analyses, especially when
considering OCD or PTSD ‒ two disorders that are quite distinct
from the others, in which relaxation could be more used as active
controls ‒ distinct time points, or high-quality studies, pointing
our results as an exploratory work with factors to be considered
in future studies; secondly, the high risk of bias in most studies;
thirdly, the fact that disorder-specific and not specific anxiety
measures were pooled, in order to gain statistical power, but at
the cost of losing sight of the specificity of changes; and finally,
the differences found, that were statistically significant, may
have no clinical relevance, especially if we consider the low statis-
tical power of the studies, which generated too wide CIs.
Implications
Despite the limitations referred, it is interesting to note that,
although in general, (C)BT could have a small advantage com-
pared with relaxation therapy in the treatment of anxiety symp-
toms, the evidence is not entirely clear and it might heavily be
influenced by the type of disorder so that different impacts
might appear as a result of treating specific anxiety disorders.
No benefit for (C)BT was found for GAD, and for panic there
is only a small advantage at the longer term. Future cost-benefit
analyses are needed to clarify in which anxiety disorders it is
worth to use (C)BT or relaxation therapy.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291717003099.
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